Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Breast cancer remains the most prevalent malignancy among women worldwide. The timely detection of this cancer type is critical for improving survival outcomes. Despite advancements, mammogram classification using deep learning strategies still faces challenges. These include inter-view feature inconsistency, loss of diagnostic details, and limited interpretability. In order to address these issue...
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy often diagnosed late due to the limited sensitivity and specificity of current modalities. To explore alternative strategies, we developed a high-dimensional immune profiling framework using 40-marker spectral flow cytometry to characterize peripheral blood from healthy individuals and treatment-naive PDAC patients across diseas...
Early detection and accurate classification of cancer are crucial to improving patient outcomes. Diagnosis and classification of tumors using conventi...
Medical professionals rely on MRI scans to evaluate brain tumors, a task prone to fatigue and subjective interpretation. This study enhances the YOLOv...
PURPOSE: Non-small cell lung carcinoma (NSCLC) is a leading cause of cancer-related mortality worldwide, highlighting the urgent need for early detect...
BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is a major cause of cancer mortality in Asia, where histopathological diagnosis of endoscopic bi...
OBJECTIVE: This bibliometric analysis systematically examined cancer research literature (2015-2024), focusing on advancements driven by machine learn...
Artificial intelligence (AI) is being used in oncological drug development to address the high costs, low success rates, and long timelines that chara...
Hepatocellular carcinoma (HCC) remains a major global health challenge due to its molecular heterogeneity, late diagnosis, and limited therapeutic opt...
INTRODUCTION: Cardiovascular-Kidney-Metabolic (CKM) syndrome reflects the convergence of cardiovascular, renal, and metabolic disorders. Metabolic dys...
Breast cancer is a life-threatening disease that is very common among women in the world. The early and correct diagnosis is necessary to enhance the ...
BACKGROUND: The response of resectable non-small cell lung cancer (NSCLC) to neoadjuvant immunotherapy is heterogeneous. Machine learning can integrat...
Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized the treatment of B-cell malignancies, with CD19 being a primary target due to its ...
Glioblastoma (GBM) is an aggressive brain tumor with highly variable patient outcomes due to pronounced molecular heterogeneity. Prognosis remains dis...
BACKGROUND: Late distant recurrence (DR) remains a significant challenge in estrogen receptor (ER)-positive/Human Epidermal Growth Factor Receptor 2 (...
BACKGROUND: Chemoradiation therapy (CRT) is standard treatment for anal squamous cell carcinoma (ASCC). Abdominoperineal resection (APR) is usually re...
Electrochemical biosensors represent an advanced and novel technology for the sensitive and specific detection of clinically relevant biomarkers. Of t...
Recent advancements in nondestructive 3D pathology offer a complement to standard histology by enabling comprehensive volumetric analyses of intact cl...
Minor salivary gland biopsy occupies a distinctive position in the evaluation of Sjögren disease (SjD), offering diagnostic and prognostic insights th...